| Scientific Name | Trastuzumab |
|---|---|
| Brand Name | Herceptin |
| Risk | Reminder of importance of cardiac monitoring guidance during trastuzumab therapy to reduce the frequency and severity of left ventricular dysfunction and congestive heart failure. |
| Safety Communication for Healthcare Professionals |
